REBOA in Nontraumatic OHCA
ConditionCardiopulmonary Arrest
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorSeoul National University Hospital
About this trial
The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.
Eligibility criteria
Qualifiers
Adult nontraumatic OHCA
Witnessed arrest
Arrival at ER from 9AM to 5PM (in South Korea) and 8AM to 8PM (in Taiwan)
Disqualifiers
age below 20 years old or over 80 years old,
traumatic cardiac arrest,
those with unwitnessed cardiac arrest,
pregnant patients,
Trial design
Treatments tested in this trial
- REBOA
Treatment groups
234 Participants
are divided into 2 treatment groupsSponsors and collaborators
Seoul National University Hospital
Lead sponsor
Far Eastern Memorial Hospital
Collaborator
Source ClinicalTrials.gov